Business Model Breakdown
How Kimberly-Clark Corp Makes Money
KMB
Market Cap
$32.3B
Annual Revenue
$16.4B
Profit Margin
11.7%
Employees
38,000
The Short Version
Kimberly-Clark manufactures and markets a diverse portfolio of essential, everyday consumer products globally. It operates through three main segments: Personal Care (diapers, wipes, feminine hygiene), Consumer Tissue (facial tissue, bathroom tissue, paper towels), and K-C Professional (away-from-home products for businesses). The company generates revenue by selling these branded products through retail channels, institutions, and businesses worldwide, capitalizing on strong brand recognition and extensive distribution networks.
Where the Revenue Comes From
Personal Care products (e.g., Huggies, Kotex) - approx. 50% of revenue
Consumer Tissue products (e.g., Kleenex, Scott) - approx. 30% of revenue
K-C Professional products (e.g., WypAll, Kleenex for Business) - approx. 20% of revenue
Who buys: Global consumers (individuals and households), businesses, government entities, and institutions.
Why It Works (Competitive Advantages)
- ✔Strong global brand recognition and loyalty
- ✔Extensive global distribution networks
- ✔Economies of scale in manufacturing and procurement
Economic Moat: Wide (Brand Power, Cost Advantages, Efficient Scale)
What Our Analysis Says
DVR Score as of April 13, 2026
Kimberly-Clark (KMB) remains a highly stable, large-cap consumer staples company with a robust portfolio of essential brands like Huggies, Kleenex, and Kotex. Its competitive advantages are formidable, rooted in strong brand recognition, extensive distribution, and economies of scale, leading to consistent profitability and a healthy balance sheet. However, the core analysis focuses on 10x growth potential within 3-5 years, which KMB fundamentally lacks. The market for essential consumer goods is mature, offering minimal organic growth. While Q1 2026 earnings are upcoming on April 28, 2026, there are no reported material changes, strategic pivots, or disruptive innovations that would propel KMB into a hyper-growth trajectory. KMB is an income-generating, defensive asset, not a high-growth investment opportunity.